Atlas
Market PulseSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › CIPLA

CIPLA

Cipla Limited
Large-capPharma ↗

What the six lenses say about CIPLA — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹1441.3
2026-07-10
VWAP · 1Y anchor
₹1420
+1.5% from VWAP
P/E · TTM
30.0×
TTM EPS ₹48.0
52-week range
53%
position low→high
RSI(14)
57
momentum

Own sector index

Pharma ↗
Overweight

1M

+6.2%

3M

+15.8%

1Y

+16.2%

Breadth >EMA21

72%

How CIPLA’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
4.5
avg conviction decile
Leadership
0/2
active lenses · Tech & Flow
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Large-cap cohortDRaw
TechnicalD655›

The actual numbers

Price vs VWAP (1y)+1.5%
EMA trend stackMixed
Price vs 200-EMA+3.1%
Price vs 50-EMA+3.3%
RSI(14)57
RS vs Nifty 500 · 3M+13.9%
RS vs sector · 3M+1.5%
52-week range53%
Volume vs 30d avg0.41×
Volume vs 60d avg0.39×
ATR(14) · volatility29.0
Bollinger width · vol contraction0.112
FundamentalD343›

The actual numbers

Return on equity (ROE)11.6%
Return on capital (ROCE)15.5%
Operating margin18.7%
Net margin13.7%
Revenue growth · YoY+2.2%
EPS growth · YoY-26.4%
Debt / equity0.02×

Full 8-quarter history in the financials table below.

ValuationD633›

The actual numbers

P/E (TTM)30.0×
TTM EPS₹48.0
52-week range53%
CatalystD546›

The actual numbers

Earnings & momentum38
Capital actions31
Governance144

Every filing in the corporate-announcements panel below.

FlowD342›

The actual numbers

Promoter holding29.2%
Delivery · 30d avg54.8%
Up/down-day asymmetry-3.7pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Large-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D6 + D3 ) ÷ 2 = 4.5(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Medium
54
Conviction score 54/100 · avg-decile strength 4.5/10
Conviction score54/100›
TechnicalD6›
FundamentalD3›
ValuationD6›
CatalystD5›
FlowD3›

Policy

Government policy · Pharma

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+0.3pp
-0.1pp
+1.4pp
+17.6pp
+5.0pp
+3.0pp
Nifty 500
Broad-market baseline
-0.1pp
-0.2pp
+0.9pp
+13.9pp
-0.0pp
-0.8pp
Sector
Own-sector index
—
—
-1.5pp
+1.5pp
-14.4pp
-18.7pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

CIPLA daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
1441.30+9.50

Relative strength

RS vs baseline · rebased to 100

CIPLA ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
94.82-0.09

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)6,6947,0517,0736,7306,9577,5897,0746,541
↳ change QoQ—+5.3%+0.3%-4.8%+3.4%+9.1%-6.8%-7.5%
EBITDA (₹cr)1,8762,0762,2111,5381,7781,8951,255955
EBITDA margin28.0%29.4%31.3%22.9%25.6%25.0%17.7%14.6%
PAT (₹cr)1,1751,3051,5751,2141,2921,353674543
↳ change QoQ—+11.0%+20.7%-22.9%+6.4%+4.7%-50.2%-19.4%
Net margin17.6%18.5%22.3%18.0%18.6%17.8%9.5%8.3%
EPS (₹)14.5816.1319.4515.1316.0616.738.376.87
D/E0.00———————
YoY growth · Mar '26Revenue -2.8% YoYPAT -55.3% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 19 Jun '26
    MEDIUMgovernance
    Disclosure under SEBI Takeover Regulations
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 16 Jun '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 16 Jun '26
    LOWgovernance
    Change in Management
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 11 Jun '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 9 Jun '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 8 Jun '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 4 Jun '26
    LOWgovernance
    ESOP/ESOS/ESPS
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 2 Jun '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 1 Jun '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 28 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 15 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 14 May '26
    LOWgovernance
    Allotment of Securities
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 May '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 May '26
    MEDIUMgovernance
    Appointment
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds CIPLA

Mutual funds holding CIPLA (10)

FundWeightAUM ₹crGrade
Parag Parikh Flexi Cap Reg Gr1.47%1,43,388
HDFC Flexi Cap Gr2.89%1,01,822
Kotak Flexicap Reg Gr0.92%55,850
Nippon India Multi Cap Bns0.64%54,585
Nippon India Multi Cap Gr0.64%54,585
Nippon India Multi Cap Dir Bns0.64%54,585
Nippon India Large Cap Gr1.13%53,227
Nippon India Large Cap Bns1.13%53,227
Nippon India Large Cap Instl Bns1.13%53,227
Nippon India Large Cap Dir Bns1.13%53,227

ETFs holding CIPLA (10)

ETFWeightGrade
Nippon India Nifty Pharma ETF8.91%
Aditya BSL Nifty Healthcare ETF7.60%
DSP Nifty Healthcare ETF7.60%
Axis NIFTY Healthcare ETF7.60%
ICICI Pru Nifty Healthcare ETF7.58%
Mirae Asset Nifty 500 Healthcare ETF6.25%
Motilal Oswal BSE Healthcare ETF5.37%
Nippon India BSE Sensex Next 30 ETF3.19%
DSP BSE Sensex Next 30 ETF3.06%
Mirae Asset Nifty 50 Equal Weight ETF2.13%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Pharma